NeoGenomics, Inc. Share Price
NYSE: NEOHealthcare
Live NeoGenomics, Inc. Share Price Chart
O H L
NeoGenomics, Inc. Performance Overview
Days Range
▼
$16.05Low
$16.60High
Markets Today
| Previous Close | $16.02 |
|---|---|
| Open | $16.07 |
| Volume | 1,321,242 |
| Day's Range | $16.05 - $16.60 |
| 52W Range | $7.07 - $20.15 |
| Market Cap | $2.06 B |
Historical Performance
| 1M Returns | -7.16 |
|---|---|
| 3M Returns | +15.88 |
| 6M Returns | +112.61 |
| 1Y Returns | +79.67 |
| 5Y Returns | -60.19 |
| 10Y Returns | +97.94 |
NeoGenomics, Inc. Fundamentals
| Market Cap | $2.06 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $727.33 M |
| ROE TTM | -0.12 |
| EPS TTM | $-0.40 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 2.61 |
| EBITDA | $-20.30 M |
| Profit Margin | -14.85 |
| Market Cap | $2.06 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $727.33 M |
| ROE TTM | -0.12 |
| EPS TTM | $-0.40 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 2.61 |
| EBITDA | $-20.30 M |
| Profit Margin | -14.85 |
NeoGenomics, Inc. Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $168.03 M | $181.33 M | $187.80 M | $190.17 M | $186.67 M | $201.66 M |
| Gross Profit + | $73.25 M | $77.26 M | $80.45 M | $83.34 M | $80.86 M | $91.88 M |
| Operating Income | -$27.82 M | -$47.63 M | -$27.01 M | -$13.41 M | -$18.24 M | -$9.77 M |
| EBITDA | -$10.10 M | -$10.32 M | -$3.49 M | $3.61 M | -$1.83 M | $6.44 M |
| Interest Expense | -$1.62 M | -$933.00 K | -$603.00 K | -$599.00 K | -$598.00 K | -$781.00 K |
| Depreciation | $17.73 M | $37.30 M | $23.52 M | $17.02 M | $16.41 M | $16.21 M |
| Income Before Tax | -$25.66 M | -$45.82 M | -$26.39 M | -$12.41 M | -$17.58 M | $1.83 M |
| Income Tax Expense | $266.00 K | -$724.00 K | $740.00 K | -$2.52 M | -$472.00 K | -$412.00 K |
| Net Income + | -$25.92 M | -$45.09 M | -$27.13 M | -$9.88 M | -$17.11 M | $2.24 M |
| Net Profit Margin | -15.43% | -24.87% | -14.45% | -5.2% | -9.16% | 1.11% |
NeoGenomics, Inc. Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $128.00 K | $128.00 K | $128.00 K | $129.00 K | $129.00 K | $130.00 K |
| Reserve & Surplus | -$351.76 M | -$396.77 M | -$423.85 M | -$433.80 M | -$450.91 M | -$448.67 M |
| Non-Current Liabilities | $433.47 M | $439.79 M | $438.62 M | $434.97 M | $433.18 M | $460.63 M |
| Current Liabilities | $279.69 M | $99.66 M | $97.39 M | $88.30 M | $84.59 M | $105.88 M |
| Total Liabilities | $713.16 M | $539.91 M | $536.49 M | $523.27 M | $517.77 M | $566.51 M |
| Fixed Assets | $420.92 M | $387.26 M | $379.63 M | $371.36 M | $362.55 M | $352.20 M |
| Current Assets | $573.93 M | $392.55 M | $382.46 M | $376.29 M | $373.68 M | $381.48 M |
| Total Assets | $1.60 B | $1.39 B | $1.37 B | $1.36 B | $1.35 B | $1.35 B |
NeoGenomics, Inc. Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$25.92 M | -$45.09 M | -$27.13 M | -$9.88 M | -$17.11 M | $2.24 M |
| Operating Cash Flow | -$25.33 M | $20.33 M | $8.88 M | $1.34 M | -$8.14 M | $19.96 M |
| Investing Cash Flow | $3.56 M | -$9.31 M | -$277.00 K | -$6.30 M | -$5.00 M | -$8.32 M |
| Financing Cash Flow | $949.00 K | -$202.43 M | $765.00 K | $431.00 K | -$338.00 K | -$12.24 M |
| Change in Cash | -$20.82 M | -$191.47 M | $9.39 M | -$4.50 M | -$13.47 M | -$604.00 K |
NeoGenomics, Inc. Return Calculator
The NeoGenomics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$3,791
Invested Amount$10,000
Est. Returns$-6,209
About NeoGenomics, Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
Popular Stocks
FAQs
What is the share price of NeoGenomics, Inc. today?
NeoGenomics, Inc. (NEO) share price as of October 10, 2026 is $15.57. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of NeoGenomics, Inc.?
Yes, Indian Investors can invest in the NeoGenomics, Inc. (NEO) Share by opening an international trading account with Angel One.
How can I purchase NeoGenomics, Inc. shares in India?
Purchasing NeoGenomics, Inc. (NEO) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying NeoGenomics, Inc. (NEO) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of NeoGenomics, Inc.?
Yes, you can purchase fractional shares of NeoGenomics, Inc. (NEO) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of NeoGenomics, Inc.?
The market capitalization of NeoGenomics, Inc. on October 10, 2026, is $2.06 B.
In which sector NeoGenomics, Inc. belongs?
NeoGenomics, Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in NeoGenomics, Inc. stocks?
In order to invest in NeoGenomics, Inc. (NEO) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
